In the most recent trading session, Organon (OGN) closed at $6.05, indicating a -4.87% shift from the previous trading day.

SG Americas Securities LLC lifted its position in Organon and Co. (NYSE: OGN) by 74.6% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 276,086 shares of the company's stock after buying an additional 117,962 shares during the period. SG

Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

In the latest trading session, Organon (OGN) closed at $5.84, marking a -3.47% move from the previous day.

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon's VTAMA (tapinarof) cream, 1% new Phase 3 pooled data analysis shows early and consistent skin clearance and itch improvements for AD patients.

VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") reports preliminary and unaudited financial results for its fourth quarter and year ended December 31, 2025. All figures are stated in Canadian dollars unless otherwise noted.

Sio initiated a new OGN position in the fourth quarter, buying up 3,421,765 shares. The quarter-end position value increased by $24.53 million as a result.

The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain Parkinson's disease treatments to ​update their prescribing information with a new warning about ‌a potential risk of seizures.

Organon (OGN) closed at $6.23 in the latest trading session, marking a -2.5% move from the prior day.

VANCOUVER, BC / ACCESS Newswire / March 18, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") announces that, further to its news release dated March 12, 2026, the Company will not be proceeding with the private placement. "Orogen is well funded to pursue its objective of project generation and royalty acquisition," commented CEO Paddy Nicol.